Exploring the burden of actinic keratoses through development of a patient decision aid: a mixed-methods study.

IF 3.7 4区 医学 Q1 DERMATOLOGY
Ciara Drumm, Aoife Moloney, Louise Fleming, Imelda Morgan, Ciara Keating, Clodagh Hughes, Roisin Dolan, Bláithín Moriarty, Aoife Lally
{"title":"Exploring the burden of actinic keratoses through development of a patient decision aid: a mixed-methods study.","authors":"Ciara Drumm, Aoife Moloney, Louise Fleming, Imelda Morgan, Ciara Keating, Clodagh Hughes, Roisin Dolan, Bláithín Moriarty, Aoife Lally","doi":"10.1093/ced/llae173","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Actinic keratoses (AKs) are present on sun-exposed sites and are considered precursors of cutaneous squamous cell carcinoma. A better understanding of the experiences of patients with this condition may improve patient-provider relationships and guide the introduction of shared decision-making (SDM) to treatment decisions.</p><p><strong>Objectives: </strong>To develop a patient decision aid (PDA) for field treatment of multiple AKs in line with the International Patient Decision Aid Standards (IPDAS) by (i) characterizing the burden and lived experiences of patients with multiple AKs, (ii) understanding the decisional needs of patients requiring field treatment, and (iii) exploring clinician preferences regarding field treatment for multiple AKs.</p><p><strong>Methods: </strong>This mixed-methods study followed the most up-to-date guidelines set out by the IPDAS collaboration; a voluntary body that aims to enhance the quality of PDAs by developing an evidence-based systematic process for the development of unbiased and effective PDAs.</p><p><strong>Results: </strong>Multiple AKs have a psychosocial impact on patients. Patients feel supported through the integration of evidence-based information to guide SDM.</p><p><strong>Conclusions: </strong>We propose that the use of a PDA for multiple AKs provides a key role in supporting informed shared patient-provider decision-making and empowers patient involvement in their prospective treatment strategy.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"1379-1388"},"PeriodicalIF":3.7000,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ced/llae173","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Actinic keratoses (AKs) are present on sun-exposed sites and are considered precursors of cutaneous squamous cell carcinoma. A better understanding of the experiences of patients with this condition may improve patient-provider relationships and guide the introduction of shared decision-making (SDM) to treatment decisions.

Objectives: To develop a patient decision aid (PDA) for field treatment of multiple AKs in line with the International Patient Decision Aid Standards (IPDAS) by (i) characterizing the burden and lived experiences of patients with multiple AKs, (ii) understanding the decisional needs of patients requiring field treatment, and (iii) exploring clinician preferences regarding field treatment for multiple AKs.

Methods: This mixed-methods study followed the most up-to-date guidelines set out by the IPDAS collaboration; a voluntary body that aims to enhance the quality of PDAs by developing an evidence-based systematic process for the development of unbiased and effective PDAs.

Results: Multiple AKs have a psychosocial impact on patients. Patients feel supported through the integration of evidence-based information to guide SDM.

Conclusions: We propose that the use of a PDA for multiple AKs provides a key role in supporting informed shared patient-provider decision-making and empowers patient involvement in their prospective treatment strategy.

通过开发患者决策辅助工具探索光化性角化病的负担:一项混合方法研究。
背景:日光性角化病(AK)出现在暴露于阳光的部位,被认为是皮肤鳞状细胞癌(cSCC)的前兆。更好地了解这种疾病患者的经历可以改善患者与医疗服务提供者之间的关系,并为在治疗决策中引入共同决策(SDM)提供指导:目的:根据国际患者决策辅助标准(IPDAS),通过(i)描述多发性光化性角化病患者的负担和生活经历,(ii)了解需要现场治疗的患者的决策需求,以及(iii)探索临床医生对多发性光化性角化病现场治疗的偏好,为多发性光化性角化病的现场治疗开发患者决策辅助工具(PDA):这项混合方法研究遵循了 IPDAS 协作组织制定的最新指导方针;IPDAS 协作组织是一个自愿性机构,旨在通过制定循证系统流程来提高 PDA 的质量,从而开发出无偏见、有效的 PDA:结果:多发性光化性角化病对患者的心理造成了影响。通过整合以证据为基础的信息来指导 SDM,患者感受到了支持:我们建议对多发性光化性角化病使用 PDA,它在支持患者与医护人员共同做出知情决策方面发挥了关键作用,并增强了患者参与其未来治疗策略的能力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.20
自引率
2.40%
发文量
389
审稿时长
3-8 weeks
期刊介绍: Clinical and Experimental Dermatology (CED) is a unique provider of relevant and educational material for practising clinicians and dermatological researchers. We support continuing professional development (CPD) of dermatology specialists to advance the understanding, management and treatment of skin disease in order to improve patient outcomes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信